Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Relative Bioavailability Study of Azacitidine 75 mg/m2 Subcutaneous Injection In Myelodysplastic Syndrome Patients Under Fasting Conditions

NCT01152346 is registered in ClinicalTrials.gov with Bioniche Pharma USA LLC as lead sponsor.

NCT NCT01152346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01152346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Relative Bioavailability Study of Azacitidine 75 mg/m2 Subcutaneous Injection In Myelodysplastic Syndrome Patients Under Fasting Conditions
Lead sponsor
Bioniche Pharma USA LLC
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2011
Completion date
May 31, 2013
Enrollment
19 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome